6.99
3.71%
0.25
After Hours:
6.91
-0.08
-1.14%
Angiodynamic Inc stock is traded at $6.99, with a volume of 413.83K.
It is up +3.71% in the last 24 hours and up +14.59% over the past month.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
See More
Previous Close:
$6.74
Open:
$6.735
24h Volume:
413.83K
Relative Volume:
0.87
Market Cap:
$278.31M
Revenue:
$324.01M
Net Income/Loss:
$-192.37M
P/E Ratio:
43.69
EPS:
0.16
Net Cash Flow:
$-23.46M
1W Performance:
+0.72%
1M Performance:
+14.59%
6M Performance:
+11.48%
1Y Performance:
+2.64%
Angiodynamic Inc Stock (ANGO) Company Profile
Name
Angiodynamic Inc
Sector
Industry
Phone
(518) 798-1215
Address
14 PLAZA DRIVE, LATHAM
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Apr-05-24 | Upgrade | Oppenheimer | Perform → Outperform |
Sep-25-23 | Initiated | H.C. Wainwright | Buy |
Apr-17-23 | Downgrade | Raymond James | Strong Buy → Outperform |
Oct-15-21 | Upgrade | Canaccord Genuity | Hold → Buy |
Aug-20-21 | Initiated | Oppenheimer | Perform |
Nov-25-20 | Upgrade | Raymond James | Mkt Perform → Strong Buy |
Apr-08-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
Apr-01-19 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Apr-03-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
Jan-05-18 | Downgrade | Craig Hallum | Buy → Hold |
Apr-07-17 | Reiterated | Cantor Fitzgerald | Overweight |
Mar-30-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
Feb-08-17 | Initiated | Barclays | Equal Weight |
Nov-04-16 | Initiated | Cantor Fitzgerald | Buy |
Apr-08-16 | Resumed | Piper Jaffray | Neutral |
Jan-08-16 | Reiterated | Canaccord Genuity | Buy |
Nov-10-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
Jul-24-15 | Initiated | KeyBanc Capital Mkts | Overweight |
Jun-19-14 | Upgrade | Canaccord Genuity | Hold → Buy |
Oct-09-12 | Reiterated | Canaccord Genuity | Hold |
Jun-25-12 | Downgrade | Canaccord Genuity | Buy → Hold |
Jul-15-11 | Upgrade | Canaccord Genuity | Hold → Buy |
Jul-15-11 | Upgrade | Stifel Nicolaus | Hold → Buy |
Jun-14-11 | Downgrade | Wedbush | Neutral → Underperform |
Sep-08-10 | Reiterated | Wedbush | Neutral |
View All
Angiodynamic Inc Stock (ANGO) Latest News
AngioDynamics Stock Plunges 13.8% in Three Months: What's Next? - MSN
AngioDynamics staying in Queensbury after all. Leaders cite changed business model. - The Post Star
SG Americas Securities LLC Invests $103,000 in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
Short Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Rises By 31.0% - MarketBeat
Cwm LLC Raises Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
Zacks Research Lowers Earnings Estimates for AngioDynamics - Defense World
Here's Why You Should Add AngioDynamics Stock to Your Portfolio - MSN
AngioDynamics (NASDAQ:ANGO) Stock Price Passes Above 200-Day Moving Average – Should You Sell? - Defense World
AngioDynamics’ NanoKnife System gains CPT codes for prostate and liver treatments - Yahoo! Voices
AngioDynamics Announces American Medical Association’s CPT® Editorial Panel Grants Category I CPT® for Irreversible Electroporation (IRE) in Prostate and Liver - StockTitan
Angiodynamic Inc (ANGO)’s stock decline to 6.33 per share - US Post News
Its Stock Has Paid Off Big Time For Angiodynamic Inc - SETE News
Angel One Profits Jump 39% Thanks To Trading Boom - Finimize
A Guide To The Risks Of Investing In Angiodynamic Inc (ANGO) - Knox Daily
AngioDynamics, Inc. (NASDAQ:ANGO) Sees Significant Decrease in Short Interest - MarketBeat
Insider Buying: Nighan Warren JR, Angiodynamic Inc [ANGO] SVP Quality and Regulatory invested 768 shares - Knox Daily
Study Begins For AngioDynamics' AlphaVac F18⁸⁵ System - MPO-mag
Perrigo Company plc [PRGO] Records 50-Day SMA of $27.19 - Knox Daily
Marshall Wace LLP Sells 218,500 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
AQR Capital Management LLC Sells 95,983 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
Mackenzie Financial Corp Acquires Shares of 13,270 AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
3 Stocks Insiders Are Buying Heavily in October and Why - Investing.com
The Angiodynamic Inc (ANGO) had a good session last reading, didn’t it? - US Post News
Dimensional Fund Advisors LP Sells 242,478 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
James C. Clemmer Buys 20,000 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) Stock - MarketBeat
AngioDynamics CFO acquires $9.96k in company stock - Investing.com
AngioDynamics, Inc. (NASDAQ:ANGO) Shares Sold by Williams & Novak LLC - Defense World
Check out these key findings about Angiodynamic Inc (ANGO) - SETE News
Analysts review Angiodynamic Inc’s rating - Knox Daily
Deeper Dive: Understanding Angiodynamic Inc (ANGO) Through its Various Ratios - The Dwinnex
Annaly Capital Management Inc [NLY] Insider Finkelstein David L sells 50,000 Shares - Knox Daily
Millennium Management LLC Raises Position in AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
Angiodynamic Inc (ANGO) Stock: Navigating Drops and Gains - The InvestChronicle
AngioDynamics slides after Q1 revenue miss - MSN
Angiodynamic Inc [ANGO] Shares Fall -16.73 % on Thursday - Knox Daily
AngioDynamics, Inc. (NASDAQ:ANGO) Misses Revenue Estimates - FXDailyReport.com
AngioDynamics Stock Up on Q1 Earnings Beat, Y/Y Pro-Forma Sales Rise - Yahoo Finance
Prepare Yourself for Liftoff: Angiodynamic Inc (ANGO) - SETE News
AngioDynamics, Inc. (NASDAQ:ANGO) Q1 2025 Earnings Call Transcript - Insider Monkey
AngioDynamics, Inc. (NASDAQ:ANGO): Are Analysts Optimistic? - Simply Wall St
AngioDynamics Sees Growth Amidst Challenges in Fiscal 2025 - Yahoo Finance
Market Momentum: Angiodynamic Inc (ANGO) Registers a -16.73 Decrease, Closing at 6.37 - The Dwinnex
NVIDIA Corp [NASDAQ: NVDA] Sees Increase in Stock Value - Knox Daily
Director MILLER JAMES H sale 1,006 shares of Crown Holdings, Inc. [CCK] - Knox Daily
AngioDynamics Inc (ANGO) Q1 2025 Earnings Call Transcript Highli - GuruFocus.com
AngioDynamics Inc (ANGO) Q1 2025 Earnings Call Transcript Highlights: A Promising Start with ... - Yahoo Finance
AngioDynamics stock slides on Q1 revenue miss (NASDAQ:ANGO) - Seeking Alpha
AngioDynamics Shares Tumble as Company Swings to 1Q Loss - MarketWatch
ANGO’s 2023 Market Dance: Down -20.15% – Time to Invest? - The InvestChronicle
ANGO’s price-to-free cash flow ratio: What it means for investors - US Post News
General Motors Company (NYSE: GM) Down -0.54%: This Is What Analysts Are Now Forecasting - Stocks Register
Angiodynamic Inc Stock (ANGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Angiodynamic Inc Stock (ANGO) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Nighan Warren JR | SVP Quality and Regulatory |
Oct 10 '24 |
Buy |
6.08 |
100 |
608 |
45,877 |
Trowbridge Stephen A | EVP and CFO |
Oct 08 '24 |
Buy |
5.86 |
1,700 |
9,962 |
172,711 |
Clemmer James C | President and CEO |
Oct 07 '24 |
Buy |
6.03 |
20,000 |
120,600 |
681,582 |
Piccinini Laura | SVP International |
Jul 17 '24 |
Option Exercise |
0.00 |
4,439 |
0 |
42,491 |
Clemmer James C | President and CEO |
Jul 17 '24 |
Option Exercise |
0.00 |
56,279 |
0 |
690,312 |
Nighan Warren JR | SVP Quality and Regulatory |
Jul 17 '24 |
Option Exercise |
0.00 |
5,677 |
0 |
46,675 |
Campbell Chad Thomas | SVP/GM, Vascular Access |
Jul 17 '24 |
Option Exercise |
0.00 |
6,600 |
0 |
70,187 |
Trowbridge Stephen A | EVP and CFO |
Jul 17 '24 |
Option Exercise |
0.00 |
11,142 |
0 |
177,612 |
Clemmer James C | President and CEO |
Apr 08 '24 |
Buy |
6.70 |
10,000 |
67,000 |
539,066 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):